← Leaderboards
Yan-Ting E. Shiu
University Of Utah
$4,275,511
Attributed
$8,330,217
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,330,217 · 5
VA$0 · 3
By mechanism
R01$8,330,217 · 5
I01$0 · 3
Top collaborators
- Roberto Irenardo Vazquez Padron10 shared
- Edgar A Jaimes4 shared
- Timmy C Lee4 shared
- John David Symons4 shared
- Vineet Gupta2 shared
Most similar at University Of Utah
Same institution · by research overlap
- Alfred K. Cheung$14,284,841
- Christi Marie Terry$589,367
Others in their field
Top investigators on “Hemodialysis”
- Gerald J Beck · Cleveland Clinic Foundation$25,607,449
- Laura M Dember · Univ Of North Carolina Chapel Hill$15,973,453
- Sanjay Misra · Mayo Clinic Rochester$12,663,075
- Myles S Wolf · Duke University$11,798,574
- Stuart Johnston Knechtle · University Of Wisconsin Madison$11,789,092
- Alfred K. Cheung · University Of Utah$11,215,629
Research focus
HemodialysisBlood VesselsBlood FlowArteriovenous FistulaHyperplasiaFailureVenousVeinsMediatingPreventSmooth Muscle MyocytesMorbidity - Disease RateMortalityIn VitroFunctional DisorderEnd Stage Renal FailureAnimalsFistulaStenosisDialysis ProcedureKnockout MiceTissuesOperative Surgical ProceduresPathologic
Grant awards (29)
Integrin Activation to Prevent Early Arteriovenous Fistula Failure in End-stage Renal Disease Patients$469,978
R01 · FY2025 · DK
BCCMA: Cardiovascular Remodeling following Arteriovenous Fistula Creation: Aging Contributes to Adverse Arteriovenous Fistula Remodeling$0
I01 · FY2025 · VA · contact PI
Translational study of RAGE-SIRT1 therapy for arteriovenous fistula maturation$0
I01 · FY2025 · VA · contact PI
Integrin Activation to Prevent Early Arteriovenous Fistula Failure in End-stage Renal Disease Patients$557,622
R01 · FY2024 · DK
Autophagy and Arteriovenous Fistula Maturation$527,748
R01 · FY2024 · HL
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation$417,075
R01 · FY2024 · DK · contact PI
Autophagy and Arteriovenous Fistula Maturation$538,518
R01 · FY2023 · HL
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation$434,453
R01 · FY2023 · DK · contact PI
Dual Role of Lysyl Oxidase in Arteriovenous Fistula Failure$362,106
R01 · FY2023 · DK
Mechanisms of imbalanced inward and outward arteriovenous fistula remodeling$0
I01 · FY2023 · VA · contact PI
Autophagy and Arteriovenous Fistula Maturation$538,518
R01 · FY2022 · HL
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation$434,453
R01 · FY2022 · DK · contact PI
Dual Role of Lysyl Oxidase in Arteriovenous Fistula Failure$375,714
R01 · FY2022 · DK
Dual Role of Lysyl Oxidase in Arteriovenous Fistula Failure$7,253
R01 · FY2022 · DK
Mechanisms of imbalanced inward and outward arteriovenous fistula remodeling$0
I01 · FY2022 · VA · contact PI
Autophagy and Arteriovenous Fistula Maturation$594,103
R01 · FY2021 · HL
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation$447,578
R01 · FY2021 · DK · contact PI
Dual Role of Lysyl Oxidase in Arteriovenous Fistula Failure$379,335
R01 · FY2021 · DK
Dual Role of Lysyl Oxidase in Arteriovenous Fistula Failure$87,041
R01 · FY2021 · DK
Mechanisms of imbalanced inward and outward arteriovenous fistula remodeling$0
I01 · FY2021 · VA · contact PI
Dual Role of Lysyl Oxidase in Arteriovenous Fistula Failure$382,889
R01 · FY2020 · DK
Dual Role of Lysyl Oxidase in Arteriovenous Fistula Failure$79,788
R01 · FY2020 · DK
Mechanisms of imbalanced inward and outward arteriovenous fistula remodeling$0
I01 · FY2020 · VA · contact PI
Dual Role of Lysyl Oxidase in Arteriovenous Fistula Failure$399,745
R01 · FY2019 · DK
Mechanisms of imbalanced inward and outward arteriovenous fistula remodeling$0
I01 · FY2019 · VA · contact PI
Mechanotransduction in Neointimal Hyperplasia Formation in Arteriovenous Grafts$324,075
R01 · FY2017 · DK · contact PI
Mechanotransduction in Neointimal Hyperplasia Formation in Arteriovenous Grafts$324,075
R01 · FY2016 · DK · contact PI
Mechanotransduction in Neointimal Hyperplasia Formation in Arteriovenous Grafts$324,075
R01 · FY2015 · DK · contact PI
Mechanotransduction in Neointimal Hyperplasia Formation in Arteriovenous Grafts$324,075
R01 · FY2014 · DK · contact PI